2020 ESMO Update Advanced ALK+ NSCLC: Should We Consider Lorlatinib a New 1L Option?
By
Lung Cancer Europe (LuCE)
FEATURING
Sanjay Popat
By
Lung Cancer Europe (LuCE)
FEATURING
Sanjay Popat
Courtesy of Lung Cancer Europe (LuCE). The full video can be found here: https://www.lungcancereurope.eu/2020/10/16/luce-webinar-esmo-2020-lung-cancer-highlights/
Login to view comments.
Click here to Login
Videos